About
Working on foundation models for RNA therapeutics.
I was an early employee at Valence Discovery, a biotech startup that spun out from Mila. I led product and strategy. Valence was acquired by Recursion (NASDAQ: RXRX) in May 2023. I stayed on afterwards to help build out the AI research engine of Recursion called Valence Labs.
Biochemist by training | Waterloo graduate
Companies (1)
Data from: waas, yc